Market Report · July 15, 2026
Report Feature
Migraine Drugs Market Trends and Forecast
The future of the migraine drugs market looks promising with opportunities in various distribution channels, like hospital pharmacy, retail pharmacies, and online pharmacy. The global migraine drugs market is expected to grow with a CAGR of 12% to 15% from 2023 to 2028. The major drivers for this market are growing cases of migraine due to stress, hormonal changes, and lifestyle diseases, increased uptake of novel drug classes, launch of calcitonin gene-related peptide (CGRP)-based therapies, and growing awareness programs regarding the prevention and treatment of migraine.
The future of the migraine drugs market looks promising with opportunities in various distribution channels, like hospital pharmacy, retail pharmacies, and online pharmacy. The global migraine drugs market is expected to grow with a CAGR of 12% to 15% from 2023 to 2028. The major drivers for this market are growing cases of migraine due to stress, hormonal changes, and lifestyle diseases, increased uptake of novel drug classes, launch of calcitonin gene-related peptide (CGRP)-based therapies, and growing awareness programs regarding the prevention and treatment of migraine.
Emerging Trends in the Migraine Drugs Market
Emerging trends, which have a direct impact on the dynamics of the industry, include rapid change in lifestyle of people, and rising R&D investment for the development of innovative drugs for the treatment of migraine.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below. To learn the scope, benefits, companies researched and other details of the global migraine drugs market report, please download the report brochure.
Migraine Drugs Market by Segments
The study includes trends and forecast for the global migraine drugs market by product type, route of administration, distribution channel, and region, as follows:
Migraine Drugs Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:
The study includes trends and forecast for the global migraine drugs market by product type, route of administration, distribution channel, and region, as follows:
Migraine Drugs Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Acute Migraine Treatment
- Preventive Migraine Treatment
Migraine Drugs Market by Route of Administration [Value ($B) Shipment Analysis from 2017 to 2028]:
- Oral
- Injectables
- Others
Migraine Drugs Market by Distribution Channel [Value ($B) Shipment Analysis from 2017 to 2028]:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Migraine Drugs Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Migraine Drugs Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, migraine drugs companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the migraine drugs companies profiled in this report include.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, migraine drugs companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the migraine drugs companies profiled in this report include.
- Allergan
- Abbott Laboratories
- AstraZeneca
- Endo International
- Eisai Co.
- Impax Laboratories
- GlaxoSmithKline
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co.
- Sanofi SA
Migraine Drugs Market Insights
- Lucintel forecasts that acute migraine treatment will remain the largest segment over the forecast period due to ease of self-administration in case of patients with symptoms of nausea and vomiting along with migraine and growing utilization in combination with preventive treatments.
- Online pharmacy is expected to remain the fastest growing segment because it provides migraine drugs through e-commerce platforms which is convenient, gives privacy of buying, hassel-free, and saves time by allowing people to refrain from waiting in queues. It is specifically helpful for individuals who live far from a regular pharmacy, the elderly, the crippled, and those who work extensively, this technique of receiving medication is both very simple and quick. In addition, the cost of delivery is far less than the expense of traveling to a regular pharmacy hence, provides additional benefit.
- APAC will remain the fastest growing region due to rising prevalence of migraine in people due to increasing stress, work pressure, changing lifestyle, and consumption of alcohol, growing public awareness about the disease, rising healthcare spending, and accessibility to healthcare facilities.
Features of the Migraine Drugs Market
- Market Size Estimates: Migraine Drugs market size estimation in terms of value ($B)
- Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Migraine Drugs market size by various segments, such as product type, route of administration, and distribution channel.
- Regional Analysis: Migraine Drugs market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different product types, routes of administration, distribution channels, and regions for the migraine drugs market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the migraine drugs market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the migraine drugs market size?
Answer: The global migraine drugs market is expected to reach an estimated $xx billion by 2028.
Q2. What is the growth forecast for migraine drugs market?
Answer: The global migraine drugs market is expected to grow with a CAGR of 12% to 15% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the migraine drugs market?
Answer: The major drivers for this market are growing cases of migraine due to stress, hormonal changes, and lifestyle diseases, increased uptake of novel drug classes, launch of calcitonin gene-related peptide (CGRP)-based therapies, and growing awareness programs regarding the prevention and treatment of migraine.
Q4. What are the major segments for migraine drugs market?
Answer: the future of the migraine drugs market looks promising with opportunities in various distribution channels, like hospital pharmacy, retail pharmacies, and online pharmacy.
Q5. What are the emerging trends in migraine drugs market?
Answer: Emerging trends, which have a direct impact on the dynamics of the industry, include rapid change in lifestyle of people and rising R&D investment for the development of innovative drugs for the treatment of migraine.
Q6. Who is the key migraine drugs companies?
Answer: Some of the key migraine drugs companies are as follows:
Q1. What is the migraine drugs market size?
Answer: The global migraine drugs market is expected to reach an estimated $xx billion by 2028.
Q2. What is the growth forecast for migraine drugs market?
Answer: The global migraine drugs market is expected to grow with a CAGR of 12% to 15% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the migraine drugs market?
Answer: The major drivers for this market are growing cases of migraine due to stress, hormonal changes, and lifestyle diseases, increased uptake of novel drug classes, launch of calcitonin gene-related peptide (CGRP)-based therapies, and growing awareness programs regarding the prevention and treatment of migraine.
Q4. What are the major segments for migraine drugs market?
Answer: the future of the migraine drugs market looks promising with opportunities in various distribution channels, like hospital pharmacy, retail pharmacies, and online pharmacy.
Q5. What are the emerging trends in migraine drugs market?
Answer: Emerging trends, which have a direct impact on the dynamics of the industry, include rapid change in lifestyle of people and rising R&D investment for the development of innovative drugs for the treatment of migraine.
Q6. Who is the key migraine drugs companies?
Answer: Some of the key migraine drugs companies are as follows:
- Allergan Plc.
- Abbott Laboratories
- AstraZeneca
- Endo International Plc.
- Eisai Co. Ltd.
- Impax Laboratories
- GlaxoSmithKline Plc.
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co.
- Sanofi SA
Q7. Which migraine drugs segment will be the largest in future?
Answer: Lucintel forecasts that acute migraine treatment will remain the largest segment over the forecast period due to ease of self-administration in case of patients with symptoms of nausea and vomiting along with migraine and growing utilization in combination with preventive treatments.
Q8. In migraine drugs market, which region is expected to be the largest in next 5 years?
Answer: APAC will remain the fastest growing region due to rising prevalence of migraine in people due to increasing stress, work pressure, changing lifestyle, and consumption of alcohol, growing public awareness about the disease, rising healthcare spending, and accessibility to healthcare facilities.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Answer: Lucintel forecasts that acute migraine treatment will remain the largest segment over the forecast period due to ease of self-administration in case of patients with symptoms of nausea and vomiting along with migraine and growing utilization in combination with preventive treatments.
Q8. In migraine drugs market, which region is expected to be the largest in next 5 years?
Answer: APAC will remain the fastest growing region due to rising prevalence of migraine in people due to increasing stress, work pressure, changing lifestyle, and consumption of alcohol, growing public awareness about the disease, rising healthcare spending, and accessibility to healthcare facilities.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Table of Contents
1. Executive Summary
6.2 Emerging Trends in the Global Migraine Drugs Market
6.1.1 Growth Opportunities for the Global Migraine Drugs Market by Product Type
6.1.2 Growth Opportunities for the Global Migraine Drugs Market by Route of Administration
6.1.3 Growth Opportunities for the Global Migraine Drugs Market by Distribution Channel
6.1.4 Growth Opportunities for the Global Migraine Drugs Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising, high-growth opportunities for the migraine drugs market by product type (acute migraine treatment and preventive migraine treatment), route of administration (oral, injectables, and others), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which region will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- • What are the business risks and competitive threats in this market?
- • What are the emerging trends in this market and the reasons behind them?
- • What are some of the changing demands of customers in the market?
- • What are the new developments in the market? Which companies are leading these developments?
- • Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- • What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- • What M&A activity did occur in the last five years and what has been the impact on the industry? For any questions related to migraine drugs market or related to migraine drugs companies, migraine drugs market size, migraine drugs market share, migraine drugs analysis, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
